MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2023 Earnings Call Transcript May 14, 2023
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the MiNK Therapeutics’ First Quarter 2023 Financial Results Call. I would now like to turn the call over to Zack Armen, Head of Investor Relations. Please go ahead.
Zack Armen: Thank you, operator, and thank you all for joining us today. Today’s call is being webcast and will be available on our website for replay. I’d like to remind...
